Cite
HARVARD Citation
Shiroyama, T. et al. (n.d.). Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer. Cancer medicine. pp. 13-20. [Online].